Turning Bacteria into Cancer-Fighting Robots Wins Researcher $1 Million Grant

Feb 29, 2008

Neil Forbes of the University of Massachusetts Amherst has received a four-year grant of more than $1 million from the National Institutes of Health to research killing cancer tumors with Salmonella bacteria. Forbes turns the bacteria into tiny terminator robots that use their own flagella to venture deep into tumors where conventional chemotherapy can’t reach. Once in place, the bacteria manufacture drugs that trigger cancer cells to kill themselves.

“When we get the Salmonella bacteria into the part of the tumor where we want them to be, we’ve programmed them to go ape,” says Forbes. “We have the bacteria release a drug to trigger a receptor in cancer cells called the “death receptor,” which induces cancer cells to kill themselves. We’ve already done this in the lab. We’ve done this successfully in cancerous mice, and it dramatically increases their survival rate.”

Normally, mice with tumors all die within 30 days. After receiving this bacterial system and getting a dose of radiation, all the mice in Forbes’ lab tests survived beyond the 30 days, which could potentially translate into many months or years in people.

“It sounds like science fiction, doesn’t it?” says Forbes, an assistant professor in the chemical engineering department. “But Salmonella are little robots that can swim wherever they want. They have propellers in the form of flagella, they have sensors to tell them where they are going and they are also little chemical factories. What we do as engineers is to control where they go, what chemical we want them to make, and when they make it.”

Using bacteria to attack cancer tumors has been tried with only moderate success for decades. But Forbes’ work with Salmonella is introducing a radical improvement called “targeted intratumoral therapeutic delivery,” which sends the bacteria into parts of the tumor that are currently beyond the reach of conventional therapies. This could translate into individualized doses of chemotherapy for human cancer patients, make therapy more specific and effective, give people smaller doses of chemicals while they are being treated and cut down on patient mortality.

The basic problem being addressed by Forbes is that some regions in any cancer tumor are impossible to reach with current chemotherapy drugs. Drug access to the tissue in any tumor is limited by the distribution of its blood vessels. Tissue located farthest from its surrounding blood vessels is the hardest for drugs to reach because the vessels act as their chemical highways into the tumor. Every tumor has a different distribution of blood vessels, depending on the nature of the tumor and the patient’s genetic makeup.

“Think of the region between blood vessels as a sponge,” explains Forbes. “The particles from a therapeutic drug tend to accumulate around the outer portions of the sponge, nearest the blood vessels, and not penetrate to the interior.”

That’s where an unlikely hero, the Salmonella bacterium, comes in. Unlike drugs (which are not alive), Salmonella can take energy from their environment and can “swim” wherever they please. They have their own outboard motors called flagella, and can travel where they want in a tumor, regardless of blood vessels. Forbes’ concept is to use special Salmonella disarmed of their toxicity and fix them with drug payloads so they can swim into these hard-to-reach regions of the tumor and kill the cancer cells there.

“The bacteria, as far as I can tell, are the only therapy that can penetrate deep into tissue, far beyond where blood vessels reach,” says Forbes.

Bacteria naturally seek out dead tissue for food by using sensors that home in on chemicals such as ribose, given off by dying cells. But Forbes doesn’t want his Salmonella robots going to the dead cancer cells already killed off by chemotherapy. He wants them penetrating to the slow-growing, but live, cancer cells that current therapy can’t touch. So his solution is to remove the ribose sensor from Salmonella.

“By knocking out the ribose receptor, we can keep the bacteria away from dead cells, where we don’t need them to go, but get them to travel into slow-growing cells located in hard-to-reach tissue far from blood vessels; the regions currently beyond our therapeutic treatment,” says Forbes.

Source: University of Massachusetts Amherst

Explore further: Protein's impact on colorectal cancer is dappled

Related Stories

Can pollution help trees fight infection?

2 hours ago

Trees that can tolerate soil pollution are also better at defending themselves against pests and pathogens. "It looks like the very act of tolerating chemical pollution may give trees an advantage from biological ...

Most internet anonymity software leaks users' details

2 hours ago

Virtual Private Networks (VPNs) are legal and increasingly popular for individuals wanting to circumvent censorship, avoid mass surveillance or access geographically limited services like Netflix and BBC ...

Improving rice flour to aid food poverty

2 hours ago

A new, high-quality rice flour could help towards aiding global food poverty. "This rice flour serves not only as an alternative to wheat flour for those with wheat intolerance, but could also help to overcome ...

In the UK, bPay offers fob, band or sticker options

3 hours ago

Method of payment: "Cash or credit?" The two options sound so yesterday. In the UK, technology support in banking offers a new type of menu—band on the wrist, fob or sticker. The three new devices from ...

WikiLeaks says NSA spied on French business

3 hours ago

WikiLeaks has released documents that it says show that the U.S. National Security Agency eavesdropped on France's top finance officials and high-stakes French export bids over a decade in what the group called targeted economic ...

Recommended for you

Protein's impact on colorectal cancer is dappled

3 hours ago

Researchers at University of California, San Diego School of Medicine have discovered a cell signaling pathway that appears to exert some control over initiation and progression of colorectal cancer, the ...

Colon cancer: Taking a step back to move forward

12 hours ago

Recent Weizmann Institute studies are revealing a complex picture of cancer progression in which certain genes that drive tumor growth in the earlier stages get suppressed in later stages - taking a step ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

bigwheel
not rated yet Feb 29, 2008
Now this is a scientist!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.